- Home
- ATO vs BNTX Comparison
ATO vs BNTX Comparison
Compare ATO & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATO | BNTX |
|---|---|---|
| Founded | 1906 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.2B | 24.8B |
| IPO Year | 1987 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ATO | BNTX |
|---|---|---|
| Price | $169.91 | $91.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $169.50 | $137.40 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 02-03-2026 | 11-03-2025 |
| Dividend Yield | ★ 2.36% | N/A |
| EPS Growth | ★ 9.22 | N/A |
| EPS | ★ 7.46 | N/A |
| Revenue | ★ $4,702,755,000.00 | $3,698,814,972.00 |
| Revenue This Year | $13.34 | $2.36 |
| Revenue Next Year | $10.43 | N/A |
| P/E Ratio | $22.68 | ★ N/A |
| Revenue Growth | ★ 12.91 | 3.70 |
| 52 Week Low | $136.05 | $81.20 |
| 52 Week High | $180.65 | $129.27 |
Technical Indicators
Market Signals| Indicator | ATO | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.62 | 32.13 |
| Support Level | $165.89 | $94.52 |
| Resistance Level | $171.42 | $97.35 |
| Average True Range (ATR) | 2.83 | 2.33 |
| MACD | -0.12 | -0.42 |
| Stochastic Oscillator | 36.43 | 2.64 |
Price Performance
Historical ComparisonAbout ATO Atmos Energy Corporation
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3.3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.